Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TVTX - Travere Therapeutics Inc

IEX Last Trade
9.48
0.120   1.266%

Share volume: 819,140
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$9.36
0.12
1.28%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
5.46%
1 Month
-0.32%
3 Months
34.90%
6 Months
21.57%
1 Year
-28.20%
2 Year
-64.12%
Key data
Stock price
$9.48
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$5.12 - $15.04
52 WEEK CHANGE
-$0.36
MARKET CAP 
724.374 M
YIELD 
N/A
SHARES OUTSTANDING 
76.491 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.86
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$669,553
AVERAGE 30 VOLUME 
$859,802
Company detail
CEO:
Region: US
Website:
Employees: 412
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news